相关实验视频

Updated: Jul 3, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

由于CD123的精确准,在囊性血细胞状细胞新生体癌症治疗中取得了突破

Serena Zanotta¹, Domenico Galati¹, Rosaria De Filippi²

¹Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Onco-Hematology and Innovative Diagnostics, Istituto Nazionale Tumori-IRCCS-Fondazione G. Pascale, 80131 Napoli, Italy.

International journal of molecular sciences

|February 10, 2024

概括

囊性血细胞状树突细胞瘤 (BPDCN) 是一种罕见的癌症,需要新的治疗方法. 针对CD123的免疫疗法非常有前途,特别是与其他药物结合使用时,可以改善患者的生存率.

科学领域:

血液学血液学血液学
在瘤学瘤学.
免疫治疗是一种免疫疗法.

背景情况:

囊性血细胞状树突细胞瘤 (BPDCN) 是一种罕见的,具有不良预后的侵袭性血液性恶性瘤.
诊断和治疗BPDCN是具有挑战性的,因为它的稀有性和缺乏标准化的协议.
传统的治疗方法,如化疗和干细胞移植,有效性有限.

研究的目的:

审查目前BPDCN处理的情况.
突出CD123向免疫疗法的潜力.
探索新的组合策略,以改善结果.

主要方法:

审查BPDCN免疫类型和分子概况的最新进展.
对CD123向疗法的正在进行的临床和研究发展进行分析.
评估潜在的组合治疗方法,包括使用阿扎丁和venetoclax的免疫疗法.

主要成果:

CD123是BPDCN中验证的治疗点.
新兴的CD123向剂 (SL-401,IMGN632,CAR T细胞,BsAb) 显示出有前途的活动.
组合疗法可以增强抗瘤反应和生存率.

结论:

针对CD123的免疫疗法代表了BPDCN治疗的重大进展.
优化治疗效果需要创新的方法和组合策略.
将针对CD123的疗法与阿扎西蒂丁和维内托克拉克斯等药物结合起来,为改善患者的治疗结果提供了希望.

关键词:

BPDCN BPDCN 在线播放癌症治疗疗法癌症治疗树突细胞是一种树突细胞.免疫疗法免疫疗法在pDCDC中,pDC是

更多相关视频

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...